iPS CARs

EHA Library, Maria Themeli, 290385

Updates in CAR T cell therapy

EHA Library, Carl June, 290370

ROR1 CAR T cell therapy in CLL and solid tumors

EHA Library, Jennifer Specht, 290383

O1.9 EARLIER STEROID USE WITH AXICABTAGENE CILOLEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA

EHA Library, Marie Jose Kersten, 290396

O1.7 HAMPERING TUMOR GLYCOSYLATION IMPROVES THE EFFICACY OF CAR-T CELLS AGAINST SOLID TUMORS

EHA Library, Camilla Sirini, 290394

O1.5 A NEW PROMISING THIRD GENERATION CAR-CD30 T-CELL THERAPY FOR CD30+ LYMPHOMAS

EHA Library, B De Angelis, 290392

O1.4 INTEGRATED DRUG PROFILING AND CRISPR SCREENING IDENTIFY ESSENTIAL PATHWAYS FOR CAR T CELL CYTOTOXICITY

EHA Library, Mikko Keränen, 290391

Improved CAR T cell approaches for lymphoid malignancies

EHA Library, Martin Pule, 290378

Introduction & welcome

EHA Library, Faculty / Presenters, 290403

HemaSphere

EHA Library, EHA Delegate, 276201

New treatment strategies in multiple myeloma

EHA Library, Philippe Moreau, 273551

NGS technologies in AML: Time to use in clinical care?

EHA Library, Torsten Haferlach, 273550

Gene therapy for hematological disorders

EHA Library, Olivier Hermine, 273549

ASCEND PHASE 3 STUDY OF ACALABRUTINIB VS INVESTIGATOR’S CHOICE OF RITUXIMAB PLUS IDELALISIB (IDR) OR BENDAMUSTINE (BR) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paolo Ghia, 273259

IN STROKE-FREE CHILDREN WITH SICKLE CELL ANEMIA AND CEREBRAL VASCULOPATHY, THE OUTCOME OF STENOSIS WAS SIGNIFICANTLY BETTER AFTER TRANSPLANTATION THAN ON CHRONIC TRANSFUSION IN A PROSPECTIVE TRIAL

EHA Library, Francoise Bernaudin, 273258

EARLY HEMATOPOIESIS TRANSLATES MICROBIAL SIGNALS TO INTESTINAL TISSUE REPAIR

EHA Library, Hitoshi Takizawa, 273257

ONTOGENIC CHANGES IN HEMATOPOIETIC HIERARCHY DETERMINES PEDIATRIC SPECIFICITY AND DISEASE PHENOTYPE IN FUSION ONCOGENE-DRIVEN MYELOID LEUKEMIA

EHA Library, Cécile Lopez, 273256

DEVELOPMENT OF A CLINICAL PREDICTION RULE FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Alejandro Lazo-Langner, 274194

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EALRY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE-BLIND RANDOMIZED CLL12 TRIAL

EHA Library, Petra Langerbeins, 273255

A PHASE 3 STUDY OF VENETOCLAX OR PLACEBO IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Shaji Kumar, 273254

HM-PRO

EHA Library, Sam Salek, 274168

CAR-T cells in MM

EHA Library, Hermann Einsele, 274163

New contact system-inhibiting anticoagulant drugs that might not increase bleeding

EHA Library, Nicola Mutch, 274244

Novel prognostic tools that identify high risk follicular lymphoma

EHA Library, Stefano Luminari, 273683

Treatment of high risk follicular lymphoma

EHA Library, Wojciech Jurczak, 273684

Follicular lymphoma genomics

EHA Library, Jessica Okosun, 273682

Stem cell derived NK cell therapy

EHA Library, Harry Dolstra, 273669

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute graft-versus-host disease

EHA Library, Anastasios Karadimitris, 273668

Mechanisms of action for different checkpoint inhibitors

EHA Library, Pedro Berraondo, 273667

Clinical value of new drugs in acute myeloid leukemia

EHA Library, Gert Ossenkoppele, 273660

Early response evaluation in AML using mass cytometry

EHA Library, Bjorn Tore Gjertsen, 273659

Epigenetics, DNA damage and immune modulation in the molecular landscape of AML

EHA Library, Feyruz Rassool, 273658

INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING ANTI-CD 19 CHIMERIC ANTIGEN RECEPTORS T-CELLS (CAR T) FOR DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). A MONOCENTRIC PRELIMINARY EXPERIENCE.

EHA Library, Roberta Di Blasi, 267395

MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) WITH T(8;21)(Q22;Q22.1); RUNX1-RUNX1T1: RESULTS OF THE AML STUDY GROUP (AMLSG)

EHA Library, Frank G. Rücker, 267370

MARS: MUTATION-ADJUSTED RISK SCORE FOR ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Mohamad Jawhar, 267365

CLINICAL EFFICACY OF A NOVEL VALIDATED PROGNOSTIC INDEX FOR TRIAL DESIGN IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA.

EHA Library, Anthony Moorman, 267375

SAFETY AND EFFICACY OF COMBINATION OF SELINEXOR, DARATUMUMAB, AND DEXAMETHASONE (SDD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) PREVIOUSLY EXPOSED TO PROTEASOME INHIBITORS AND IMMUNOMODULATORY DRUGS

EHA Library, Cristina J. Gasparetto, 267360

INCOMPLETE COUNT RECOVERY IN PATIENTS WITH COMPLETE REMISSION PRIOR TO ALLOGENEIC HCT FOR AML IS ASSOCIATED WITH A HIGH NON-RELAPSE MORTALITY WITHOUT AN INCREASED RELAPSE RISK

EHA Library, Andrew Innes, 267380

THE COMBINATION OF LOW ADAMTS-13 ACTIVITY AND HIGH ANTI-ADAMTS13 ANTIBODIES AT REMISSION HIGHLY PREDICTS DISEASE RELAPSE IN PATIENTS WITH ACQUIRED TTP: A MULTI-INSTITUTIONAL STUDY

EHA Library, Francesca Schieppati, 267400

NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE 2 CHECKMATE 436 STUDY

EHA Library, Pier Luigi Zinzani, 267355

FRACTIONATED DOSING OF ARI-0001 CELLS (A3B1:CD8:4-1BB:CD3Z CAR19) AND EARLY TOCILIZUMAB ADMINISTRATION MAY REDUCE THE INCIDENCE OF SEVERE CYTOKINE RELEASE SYNDROME IN PATIENTS WITH CD19+ MALIGNANCIES

EHA Library, Valentín Ortiz-Maldonado, 267390

UNEXPECTED DIFFERENCES IN CARDIAC IRON METABOLISM AND SURVIVAL IN HAMP-KO AND FPN(C326S) MICE

EHA Library, Sandro Altamura, 267385

POLYMORPHISMS IN CYTOKINES, CHEMOKINES AND THEIR RECEPTORS GENES CONTRIBUTED TO CYTOMEGALOVIRUS REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Miren Vallejo, 267394

MASKED POLYCYTHEMIA VERA: ANALYSIS OF A SINGLE CENTER SERIES OF 2480 RED CELL MASSES.

EHA Library, Juliette SORET-DULPHY, 267364

NELARABINE AS SALVAGE THERAPY AND BRIDGE TO ALLOGENEIC STEM CELLS TRANSPLANTATION IN 118 ADULT PATIENTS WITH RELAPSED/REFRACTORY T-ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA. A CAMPUS-ALL, PHASE 4, STUDY.

EHA Library, Anna CANDONI, 267374

SAFETY, EFFICACY, AND BIOMARKERS OF RESPONSE TO AZACITIDINE (AZA) WITH NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI), AND AZA WITH NIVO IN R/R ACUTE MYELOID LEUKEMIA: A NON-RANDOMIZED, PHASE 2 STUDY.

EHA Library, Naval Daver, 267369

HORIZON (OP-106): UPDATED EFFICACY AND SAFETY OF MELFLUFEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO DARATUMUMAB (DARA) AND/OR POMALIDOMIDE (POM)

EHA Library, Paul G. Richardson, 267359

REDUCTION OF GRAFT-VERSUS-HOST DISEASE USING DUAL LYMPHOCYTE SUPPRESSION WITH ANTI-THYMOCYTE GLOBULIN AND LOW-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HAPLOIDENTICAL PATIENTS AT HIGH GVHD RISK

EHA Library, Yu Wang, 267379

A PHASE IIA STUDY TO EVALUATE THE SAFETY, PK AND PD OF REPEATED ADMINISTRATIONS OF THE HEPCIDIN ANTAGONIST PRS-080 IN ANEMIC CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS

EHA Library, Lutz Renders, 267384

REAL-WORLD RESULTS ON CD19 CAR T-CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE (ATU) PROGRAM

EHA Library, Catherine Thieblemont, 267354

NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY

EHA Library, Vladimir Otasevic, 267399

ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA

EHA Library, Francesca del bufalo, 267389

A PHASE I FIRST-IN-HUMAN CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION

EHA Library, M. Lia Palomba, 267388

ERFE-A260S ACCOUNTS FOR HEPATIC IRON METABOLISM IMPAIRMENT BY ACTING ON THE BMP-SMAD PATHWAY

EHA Library, Roberta Russo, 267383

A DAY 100 LAB-SCORE PREDICTS EXTENSIVE CGVHD, OVERALL SURVIVAL AND TRANSPLANT-RELATED MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL ANALYSIS

EHA Library, Andrea Bacigalupo, 267378

BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH B­CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP­ALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS

EHA Library, Nicola Goekbuget, 267373

SAFETY AND EFFICACY OF LIVE ATTENUATED VARICELLA VACCINE FOR PREVENTING VARICELLA ZOSTER VIRUS DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Koji Kawamura, 267393

CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIA

EHA Library, Linus Angenendt, 267368

THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Trine Alma Knudsen, 267363

EFFECTIVENESS OF DENOSUMAB COMPARED TO ZOLEDRONIC ACID IN BONE DISEASE TREATMENT OF MULTIPLE MYELOMA (MM): A META-ANALYSIS

EHA Library, James Abraham Malala, 267358

RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON-NORDIC LYMPHOMA GROUP PHASE III STUDY

EHA Library, Pieternella (Elly) Lugtenburg, 267353

ASSOCIATION OF SYSTEMIC CYTOKINE LEVELS WITH RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH GLIOMA

EHA Library, Pegah Mir Seyed Nazari, 267398

INCIDENCE, RISK FACTORS AND OUTCOMES OF THROMBOEMBOLISM EVENTS IN HAPLOIDENTICAL VS. MATCHED RELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Hui Zhang, 267397

BASELINE TOTAL METABOLIC TUMOR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL

EHA Library, Marek Trneny, 267352

INTERRUPTING QUINOLONE PROPHYLAXIS IN HEMATOLOGIC PATIENTS WITH PROLONGED NEUTROPENIA: AN OBSERVATIONAL STUDY

EHA Library, Alvaro Bienert García, 267392

FIRST CLINICAL (PHASE 1B/2A) STUDY OF IBERDOMIDE (CC-220; IBER), A CELMOD, IN COMBINATION WITH DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Sagar Lonial, 267357

UPDATED RESULTS FROM THE HGB-206 STUDY IN PATIENTS WITH SEVERE SICKLE CELL DISEASE TREATED UNDER A REVISED PROTOCOL WITH LENTIGLOBIN GENE THERAPY USING PLERIXAFOR-MOBILISED HAEMATOPOIETIC STEM CELLS

EHA Library, Julie Kanter, 267387

RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA: RESULTS FROM THE MPNSG-0212 COMBINATION TRIAL (NCT01644110)

EHA Library, Frank Stegelmann, 267362

TARGETING THE IMMUNOPHILIN FKBP12 BY DRUG REPURPOSING OR RNASE-BASED APPROACHES FOR BMP-SMAD PATHWAY AND HEPCIDIN UPREGULATION IN HEREDITARY HEMOCHROMATOSIS

EHA Library, Mariateresa Pettinato, 267382

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION CAN ABROGATE INCREASING RISK OF RELAPSE FROM PERSISTENT MUTATIONS MEASURED BY TARGETED SEQUENCING AT REMISSION IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Taehyung Kim, 267367

TISAGENLECLEUCEL APPEARS EFFECTIVE AND SAFE IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH-RISK CYTOGENETIC ABNORMALITIES

EHA Library, Stephan A. Grupp, 267372

INTESTINAL MICROBIOTA CAN PREDICT AGVHD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lijie Han, 267377

TANDEM AUTOLOGOUS-REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH-RISK RELAPSED HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY OF THE LWP-EBMT

EHA Library, Leyre Bento de Miguel, 267376

A DASATINIB-BLINATUMOMAB COMBINATION FOR THE FRONT-LINE TREATMENT OF ADULT PH+ ALL PATIENTS. PRELIMINARY RESULTS OF THE GIMEMA LAL2116 D-ALBA TRIAL; ON BEHALF OF GIMEMA ACUTE LEUKEMIA WORKING PARTY

EHA Library, Sabina Chiaretti, 267371

THE HEMOCHROMATOSIS PROTEINS HJV AND TFR2 ARE DISPENSABLE FOR ACUTE BMP2-MEDIATED HEPCIDIN UPREGULATION IN MICE

EHA Library, Alessia Pagani, 267381

MOLECULAR MRD STATUS AND OUTCOME AFTER TRANSPLANTATION IN NPM1 MUTATED AML: RESULTS FROM THE UK NCRI AML17 STUDY

EHA Library, Dillon RICHARD, 267366

SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY

EHA Library, Franco Locatelli, 267386

MOLECULAR ANALYSIS IN MAJIC PV CORRELATION WITH CLINICAL ENDPOINTS.

EHA Library, Natalia Curto-Garcia, 267361

A BAL-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES CLINICAL OUTCOME IN HEMATOLOGIC MALIGNANCIES PATIENTS WITH LUNG INFILTRATES DETECTION: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP

EHA Library, Francesco Marchesi, 267391

CARFILZOMIB AND DEXAMETHASONE MAINTENANCE PROLONG TIME TO PROGRESSION FOLLOWING SALVAGE ASCT IN MULTIPLE MYELOMA: A RANDOMIZED PHASE 2 TRIAL BY THE NORDIC MYELOMA STUDY GROUP

EHA Library, Henrik Gregersen, 267356

DEVELOPMENT OF A CLINICAL PREDICTION RULE FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Alejandro Lazo-Langner, 267396

PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) : THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)

EHA Library, Monica Balzarotti, 267351

From intracellular antibodies to antibody derived compounds targeting oncogenic proteins in leukemia

EHA Library, Terry Rabbitts, 274205

Neonatal leukemia

EHA Library, Irene Roberts, 274206

Management of pregnant women with inherited platelet defect

EHA Library, Patrizia Noris, 274209

Impact of stigma on psychosocial aspects of sickle cell disease

EHA Library, Kofi Anie, 273547

MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW-CYTOMETRY IS A RELIABLE TOOL FOR RISK-STRATIFICATION OF FLT3-MUTATED AML PATIENTS.

EHA Library, Raffaele Palmieri, 266628

IDH2 GENE MUTATIONS DETECTION IN ACUTE MYELOID LEUKEMIA: SCREENING AND MRD MONITORING BY “DROP-OFF” DDPCR.

EHA Library, Susanna Grassi, 266627

INDIVIDUALIZED FOLLOW-UP IN ADULT ACUTE MYELOID LEUKEMIA USING NGS

EHA Library, Zuriñe Blasco Iturri, 266626

A NEW NEXT-GENERATION SEQUENCING STRATEGY FOR THE SIMULTANEOUS DETECTION OF GENE MUTATIONS AND COPY NUMBER VARIATIONS IN MYELOID MALIGNANCIES

EHA Library, Ramon Garcia-Sanz, 266625

NORMAL AND LEUKEMIC BONE MARROW STROMAL CELLS HAVE DIFFERENT CAPACITIES FOR MITOCHONDRIA TRANSFER TO ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Mariane Cristina Do Nascimento, 266624

INHIBITORS OF HOXA9 LEUKEMOGENIC TRANSCRIPTION FACTOR ARE EFFICIENT ON HUMAN AML CELL MODELS BUT NOT ON NORMAL HUMAN BONE MARROW CD34+ HEMATOPOIETIC CELLS

EHA Library, Marie-Helene David-Cordonnier, 266623

WHOLE-TRANSCRIPTOME SEQUENCING OF CYTOGENETICALLY NORMAL PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Lilit Ghukasyan, 266622

PTC299 IS A NOVEL DHODH INHIBITOR FOR USE IN TREATMENT OF AML

EHA Library, Marla Weetall, 266621

HARMONY ALLIANCE: EUROPEAN PUBLIC-PRIVATE DATA COLLECTION LEADS THE WAY - FIRST RESULTS OF THE “PROOF-OF-PRINCIPLE” STUDY IN ACUTE MYELOID LEUKEMIA

EHA Library, Lars Bullinger, 266620

RHOE, CXCL12 AND CXCR3 MAY IDENTIFY COMPLETE RESPONSES IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH TIPIFARNIB

EHA Library, Antonio Gualberto, 266619

HACE1, A NOVEL TUMOR SUPPRESSOR GENE WHICH REGULATE THE RESPONSE OF VENETOCLAX, GANT61 AND NECROPTOSIS ACTIVATORS BY CONTROLLING C-FLIP, GLI2 AND BCL2 GENES IN ACUTE MYELOID LEUKEMIA

EHA Library, Andoni Garitano, 266618

POST-TRANSLATIONAL MODIFICATIONS OF PROTEIN PHOSPHATASE 2A (PP2A) IN MIXED LINEAGE LEUKEMIA (MLL)

EHA Library, Yoana ARROYO, 266617

SLAMF7 HIGH CD16 NEGATIVE MONOCYTES INCREASE IN PERIPHERAL BLOOD OF PATIENTS WITH MYELOFIBROSIS IN CORRELATION WITH JAK2V617F MUTATION

EHA Library, Shoichiro Kato, 266452

GENOMIC LANDSCAPE AND MOLECULAR RISK IN PATIENTS WITH DIPSS LOW- AND INTERMEDIATE-1-RISK PRIMARY MYELOFIBROSIS: A STUDY OF THE GERMAN STUDY GROUP FOR MYELOPROLIFERATIVE NEOPLASMS (GSG-MPN)

EHA Library, Ekaterina Panina, 266451